Sanofi Consumer Healthcare India Limited has announced a Board Meeting scheduled for Wednesday, February 25, 2026. The primary agenda is to consider and approve the Audited Financial Statements for the Quarter and Full Financial Year ended December 31, 2025. Consequently, the company has confirmed the continuation of the trading window closure for insiders until February 27, 2026.
Announcement of Board Meeting Date
Sanofi Consumer Healthcare India Limited has formally notified the stock exchanges regarding an upcoming meeting of its Board of Directors. The meeting is scheduled to take place on Wednesday, February 25, 2026.
Agenda for Financial Review
The principal item on the agenda for this meeting is to review, consider, and approve the finalized Audited Financial Statements. These statements cover both the financial quarter and the entire financial year that concluded on December 31, 2025.
Insider Trading Window Closure Extended
Further referencing a prior communication dated December 26, 2025, the company confirmed the status of its insider trading window. In adherence to the internal Code of Conduct, the trading window for designated persons will remain closed. This closure is specifically related to the publication of the Audited Financial Statements for the period ending December 31, 2025, and will be in effect from Thursday, January 1, 2026, through Friday, February 27, 2026 (inclusive of both dates).
Compliance Authorization
The official intimation was provided by Nikunjkumar Savaliya, the Company Secretary and Compliance Officer, bearing Membership No.: F7048.
Source: BSE
